Side-by-side comparison of AI visibility scores, market position, and capabilities
Mendaera is developing robotic systems that combine real-time imaging and AI guidance to enable minimally invasive procedures with greater precision and speed; raised $100M in a 2024 Series B led by GV and Bessemer;
Mendaera is a San Francisco-based medical technology company developing a new class of robotic systems designed to make minimally invasive procedures faster, more precise, and more accessible across a broader range of clinical settings. The company's platform integrates real-time imaging — including ultrasound and CT fluoroscopy — with AI-powered guidance and robotic actuation to assist clinicians performing needle-based interventions such as biopsies, fluid drainage, nerve blocks, and targeted drug delivery. By automating the most technically demanding aspects of needle placement, Mendaera's system aims to reduce procedure time, decrease complication rates, and enable procedures to be performed at the bedside or in community hospitals rather than exclusively in specialized interventional suites.
Global biopharma with $63.6B FY2024 revenue; $43B Seagen ADC acquisition rebuilds post-COVID pipeline; patent cliff 2026-2028 for Eliquis; activist Starboard Value pushing restructuring.
Pfizer is one of the world's largest biopharmaceutical companies, founded in 1849 by cousins Charles Pfizer and Charles Erhart in Brooklyn, New York, and now headquartered in New York City. The company trades on NYSE (PFE) and reported $63.6 billion in total revenues for FY2024, normalizing from pandemic highs of $100 billion-plus in 2021-2022 driven by Comirnaty COVID-19 vaccine revenues with BioNTech and Paxlovid COVID antiviral sales. CEO Albert Bourla has led a strategic pivot to reset the company's long-term growth profile, anchored by the landmark $43 billion acquisition of Seagen in December 2023, adding a world-class antibody-drug conjugate (ADC) oncology pipeline including Padcev, Tukysa, Adcetris, and Tivdak.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.